VKTX Covered Call Strategy
VKTX (Viking Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation of novel treatments for metabolic and endocrine conditions. The company's leading investigational drug, VK2809, is an orally administered, tissue and receptor-selective agonist of the thyroid hormone receptor beta (TRß). This compound is currently progressing through Phase IIb clinical trials, targeting both non-alcoholic steatohepatitis (NASH) in biopsy-confirmed patients and non-alcoholic fatty liver disease (NAFLD). Viking's pipeline also features VK5211, an oral, non-steroidal selective androgen receptor modulator undergoing Phase II studies for individuals recuperating from non-elective hip fracture surgery. Additionally, VK0612, an oral drug candidate for type 2 diabetes, is poised to enter Phase IIb trials. The firm is also developing VK0214, another orally active, tissue and receptor-selective TRß agonist, specifically aimed at X-linked adrenoleukodystrophy.
VKTX (Viking Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $3.73B, a beta of 0.65 versus the broader market, a 52-week range of 23.82-43.1, average daily share volume of 4.2M, a public-listing history dating back to 2015, approximately 65 full-time employees. These structural characteristics shape how VKTX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.65 indicates VKTX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a covered call on VKTX?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
VKTX snapshot
As of November 13, 2026, spot at $28.97, ATM IV 74.90%, IV rank 27.75%, expected move 21.47%. The covered call on VKTX below is built from the November 13, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this covered call structure on VKTX specifically: VKTX IV at 74.90% is on the cheap side of its 1-year range, which means a premium-selling VKTX covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 21.47% (roughly $6.22 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated VKTX expiries trade a higher absolute premium for lower per-day decay. Position sizing on VKTX should anchor to the underlying notional of $28.97 per share and to the trader's directional view on VKTX stock.
VKTX covered call setup
The VKTX covered call below is built from the November 13, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With VKTX at $28.97 on that close, the first option leg uses a $30.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed VKTX chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 VKTX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $28.97 | long |
| Sell 1 | Call | $30.00 | $2.55 |
VKTX covered call risk and reward
- Net Premium / Debit
- -$2,642.00
- Max Profit (per contract)
- $358.00
- Max Loss (per contract)
- -$2,641.00
- Breakeven(s)
- $26.42
- Risk / Reward Ratio
- 0.136
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
VKTX covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on VKTX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$2,641.00 |
| $6.41 | -77.9% | -$2,000.57 |
| $12.82 | -55.8% | -$1,360.14 |
| $19.22 | -33.6% | -$719.70 |
| $25.63 | -11.5% | -$79.27 |
| $32.03 | +10.6% | +$358.00 |
| $38.44 | +32.7% | +$358.00 |
| $44.84 | +54.8% | +$358.00 |
| $51.24 | +76.9% | +$358.00 |
| $57.65 | +99.0% | +$358.00 |
When traders use covered call on VKTX
Covered calls on VKTX are an income strategy run on existing VKTX stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
VKTX thesis for this covered call
The market-implied 1-standard-deviation range for VKTX extends from approximately $22.75 on the downside to $35.19 on the upside. A VKTX covered call collects premium on an existing long VKTX position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether VKTX will breach that level within the expiration window. Current VKTX IV rank near 27.75% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on VKTX at 74.90%. As a Healthcare name, VKTX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to VKTX-specific events.
VKTX covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. VKTX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move VKTX alongside the broader basket even when VKTX-specific fundamentals are unchanged. Short-premium structures like a covered call on VKTX carry tail risk when realized volatility exceeds the implied move; review historical VKTX earnings reactions and macro stress periods before sizing. Always rebuild the position from current VKTX chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on VKTX?
- A covered call on VKTX is the covered call strategy applied to VKTX (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With VKTX stock at $28.97 on the November 13, 2026 close, the strikes shown on this page are snapped to the nearest listed VKTX chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are VKTX covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the VKTX covered call priced from the November 13, 2026 end-of-day chain at a 30-day expiry (ATM IV 74.90%), the computed maximum profit is $358.00 per contract and the computed maximum loss is -$2,641.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a VKTX covered call?
- The breakeven for the VKTX covered call priced on this page is roughly $26.42 at expiration, derived from the November 13, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The VKTX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 21.47%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on VKTX?
- Covered calls on VKTX are an income strategy run on existing VKTX stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current VKTX implied volatility affect this covered call?
- VKTX ATM IV is at 74.90% with IV rank near 27.75%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.